Page last updated: 2024-12-08
agrimonolide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
agrimonolide: anticestodal agent from Chinese medicinal plant Agrimonia pilosa Ledeb [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Related Flora
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Agrimonia | genus | A plant genus of the family ROSACEAE that has been used in folk treatment of diabetes. Members contain agrimoniin (TANNINS).[MeSH] | Rosaceae | The rose plant family in the order ROSALES and class Magnoliopsida. They are generally woody plants. A number of the species of this family contain cyanogenic compounds.[MeSH] |
| Agrimonia pilosa | species | [no description available] | Rosaceae | The rose plant family in the order ROSALES and class Magnoliopsida. They are generally woody plants. A number of the species of this family contain cyanogenic compounds.[MeSH] |
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 161362 |
| MeSH ID | M0110084 |
Synonyms (12)
| Synonym |
|---|
| 21499-24-1 |
| MEGXP0_000428 |
| agrimonolide |
| (3s)-6,8-dihydroxy-3-[2-(4-methoxyphenyl)ethyl]-3,4-dihydroisochromen-1-one |
| 1h-2-benzopyran-1-one, 3,4-dihydro-6,8-dihydroxy-3-(2-(4-methoxyphenyl)ethyl)-, (s)- |
| 3,4-dihydro-6,8-dihydroxy-3-(2-(4-methoxyphenyl)ethyl)-1h-2-benzopyran-1-one |
| 6,8-dihydroxy-3-[2-(4-methoxyphenyl)ethyl]-3,4-dihydro-1h-2-benzopyran-1-one |
| DTXSID70944104 |
| isocoumarin, 3,4-dihydro-6,8-dihydroxy-3-(p-methoxyphenethyl)-, (s)- |
| MS-24615 |
| GLXC-17083 |
| AKOS040761325 |
Research Excerpts
Overview
Agrimonolide is a monomeric component extracted from Agrimonia pilosa L.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Agrimonolide (AM) is a monomeric component extracted from Agrimonia pilosa L." | ( Protective effects of agrimonolide on hypoxia-induced H9c2 cell injury by maintaining mitochondrial homeostasis. Cheng, G; Li, L; Liu, J; Liu, M; Qi, C; Wang, C; Wang, L; Xing, Y; Zhao, X, 2022) | 1.76 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 20.13
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.13) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (11.11%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (88.89%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||